Introduction
PGS/PGT-A is a testing process associted with IVF procedure. It is carried out on the 5th or 6th day of the growing in vitro fertilized embryo. A small sample of cells is taken from the embryo for analysis to determine if it has any abnormal chromosome numbers.
By using PGS/PGT-A screening, embryos with the correct number of chromosomes can be selected for implantation. This not only increases the success rate of embryo implantation but also significantly reduces the risk of miscarriage in women, thereby improving the live birth rate of the fetus.
Features / strengths
●A CAP/LDTS dual-certified laboratory.
●The specimens are transported using high-quality dry ice shipping methods, effectively reducing the failuare rate.
●We offer two exclusive formulas to facilitate embryo specimen collection. These formulas stabilize DNA and prevent cell adhesion to the tube walls during cell biopsy.
●Each embryo specimen undergoes dual QC confirmation of sample quality after WGA amplification, ensuring patients don't incur unnecessary expenses.
●We provide two supplementary reports for clinical reference by physicians: a mosaic report and a mitochondrial mtDNA Score report.
●Our professional genetic counseling team offers pre-test technical consultation for clinical physicians, as well as post-test report consultations.
●We assist in post-implantation chromosome tracking for prenatal testing, helping physicians monitor the ongoing condition of both the patient and the fetus.
Specification in detail
